Trial · NCT03068754
Participant flow64
How many started, completed or left each group, period by period.
1 to 20 of 64
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Randomized Treatment Period (RTP) | STARTED | Arm A: Randomized Treatment Period (RTP) Acthar Gel | 95 | |
| Randomized Treatment Period (RTP) | STARTED | Arm B: RTP Placebo | 48 | |
| Randomized Treatment Period (RTP) | STARTED | Arm C: Open Label Extension Period (OLE) Acthar Gel-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | STARTED | Arm D: OLE Placebo-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | Intention to Treat (ITT) Population | Arm A: Randomized Treatment Period (RTP) Acthar Gel | 95 | |
| Randomized Treatment Period (RTP) | Intention to Treat (ITT) Population | Arm B: RTP Placebo | 48 | |
| Randomized Treatment Period (RTP) | Intention to Treat (ITT) Population | Arm C: Open Label Extension Period (OLE) Acthar Gel-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | Intention to Treat (ITT) Population | Arm D: OLE Placebo-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | Safety Population | Arm A: Randomized Treatment Period (RTP) Acthar Gel | 95 | |
| Randomized Treatment Period (RTP) | Safety Population | Arm B: RTP Placebo | 47 | |
| Randomized Treatment Period (RTP) | Safety Population | Arm C: Open Label Extension Period (OLE) Acthar Gel-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | Safety Population | Arm D: OLE Placebo-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | Modified ITT (mITT) | Arm A: Randomized Treatment Period (RTP) Acthar Gel | 93 | |
| Randomized Treatment Period (RTP) | Modified ITT (mITT) | Arm B: RTP Placebo | 46 | |
| Randomized Treatment Period (RTP) | Modified ITT (mITT) | Arm C: Open Label Extension Period (OLE) Acthar Gel-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | Modified ITT (mITT) | Arm D: OLE Placebo-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | Completed Taper | Arm A: Randomized Treatment Period (RTP) Acthar Gel | 58 | |
| Randomized Treatment Period (RTP) | Completed Taper | Arm B: RTP Placebo | 28 | |
| Randomized Treatment Period (RTP) | Completed Taper | Arm C: Open Label Extension Period (OLE) Acthar Gel-Acthar Gel | 0 | |
| Randomized Treatment Period (RTP) | Completed Taper | Arm D: OLE Placebo-Acthar Gel | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03068754/flow